Greenleaf Trust Cuts Stock Position in Humana Inc. (NYSE:HUM)

Greenleaf Trust decreased its holdings in Humana Inc. (NYSE:HUM) by 30.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,056 shares of the insurance provider’s stock after selling 892 shares during the quarter. Greenleaf Trust’s holdings in Humana were worth $522,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Creative Financial Designs Inc. ADV grew its stake in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. Atwood & Palmer Inc. purchased a new position in shares of Humana in the 3rd quarter valued at about $29,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana in the 3rd quarter valued at about $31,000. Your Advocates Ltd. LLP boosted its stake in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the period. Finally, LRI Investments LLC boosted its stake in shares of Humana by 1,021.4% in the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider’s stock valued at $50,000 after buying an additional 143 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.29% of the company’s stock.

Humana Trading Up 0.9 %

NYSE HUM opened at $295.68 on Wednesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $35.60 billion, a P/E ratio of 26.19, a P/E/G ratio of 2.21 and a beta of 0.56. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The firm has a 50-day moving average price of $275.13 and a 200 day moving average price of $300.37.

Analysts Set New Price Targets

Several brokerages have recently issued reports on HUM. KeyCorp began coverage on shares of Humana in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Stephens restated an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Morgan Stanley raised their price objective on shares of Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. TD Cowen increased their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Nineteen analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $297.68.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.